Cencora announces Q3 FY26 earnings release date

1 min read     Updated on 02 Jul 2026, 04:13 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Cencora, Inc. has scheduled the release of its third quarter fiscal 2026 financial results for August 5, 2026, before the market opens. A conference call featuring CEO Robert P. Mauch and CFO Eva C. Boratto will follow at 8:30 a.m. ET to discuss the performance. Investors can access the call via telephone or a live webcast on the company's website.

powered bylight_fuzz_icon
44491387

*this image is generated using AI for illustrative purposes only.

Cencora, Inc. will release its financial results for the third quarter of fiscal 2026 on August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026. This announcement provides investors with the timeline for accessing the upcoming quarterly performance data.

Conference Call Details

Participating in the conference call will be Robert P. Mauch, President & Chief Executive Officer, and Eva C. Boratto, Executive Vice President & Chief Financial Officer. The live call will be webcast via the company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time.

Access Information

To access the call via telephone from within the United States and Canada, dial +1 (833) 461-5787. From outside the United States and Canada, dial +1 (585) 542-9983. The meeting ID for the call will be 632 369 927.

Access Method Details
US/Canada Dial-in +1 (833) 461-5787
International Dial-in +1 (585) 542-9983
Meeting ID 632 369 927
Webcast Link investor.cencora.com

Replay Availability

A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year. Investors are advised to check the website for updates regarding the timing of the live webcasts and for replay information.

What key performance indicators will investors focus on during the Q3 fiscal 2026 earnings call?

How might Cencora's Q3 results impact its stock price and investor sentiment?

What strategic initiatives or market trends could influence Cencora's financial performance in the upcoming quarters?

like16
dislike

B of A Securities maintains Neutral on Cencora, raises target to $285

0 min read     Updated on 24 Jun 2026, 11:02 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

B of A Securities analyst Michael Funk maintained a Neutral rating on Cencora (NYSE: COR) and raised the price target to $285 from $280, reflecting a modest valuation adjustment.

powered bylight_fuzz_icon
43867913

*this image is generated using AI for illustrative purposes only.

B of A Securities analyst Michael Funk has maintained a Neutral rating on Cencora (NYSE: COR) and increased the price target to $285 from $280. The adjustment reflects a revised valuation outlook for the pharmaceutical distributor.

The revised target comes as the firm evaluates Cencora's current market position and future performance potential. Despite the higher target, the Neutral stance suggests the stock is expected to perform in line with the broader market.

Rating and Target Details

Metric Value
Rating Neutral
Previous Price Target $280
New Price Target $285

The price target increase indicates a modest upward revision in the firm's expectations, though the overall investment thesis remains unchanged.

What specific factors drove the modest $5 increase in Cencora's price target?

How might Cencora's future performance compare to its competitors in the pharmaceutical distribution sector?

What risks or opportunities could prompt B of A Securities to shift its Neutral rating in the future?

like20
dislike

More News on Cencora Inc